Pharmaco-metabolomics

Pharmaco-metabolomics used to determine the metabolic biomarkers that could potentially predict different responses of clinical drugs by identifying differential metabolites at baseline and correlating their variations with the therapeutic outcomes. Presently, Pharmaco-metabolomics remains in its infancy because most pharmaco-metabolomics studies are merely focused on revealing the correlation between baseline metabotypes which are influenced by factors like-gut, ages, drug intake and diets microbiota with drug responses or disease susceptibility to review and decrease the metabolic bases.

 

    Related Conference of Pharmaco-metabolomics

    September 29-30, 2025

    21st World Congress on Structural Biology

    Aix-en-Provence, France
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    A Coruna, Spain

    Pharmaco-metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in